Nicotinamide, also known as niacinamide or nicotinic acid amide, is the water-soluble, active form of vitamin B3. It is made in the body by eating niacin-rich foods such as fish, poultry, nuts, legumes, eggs, and cereal grains. Nicotinamide supplements are used to treat skin conditions and niacin deficiencies. It has also been incorporated in many topical agents including sunscreens and cosmetic agents. The nicotinamide market in China, in terms of revenue, is expected to grow by 5.2 percent annually through 2028, according to a new report by Gen Consulting Company.

This industry report offers market estimates of the China market, followed by a detailed analysis of the application. The China market data on nicotinamide can be segmented by application: animal feed, cosmetics, food, pharmaceuticals, others.

The China nicotinamide market is highly competitive. The nicotinamide market is dominated by key players, which are Brother Enterprises Holding Co. Ltd., Hebei Yanuo Bioscience Co. Ltd., Hubei Ruibang Biotechnology Co. Ltd., Jubilant Life Sciences Limited, Lonza Group AG, Nanjing Red Sun Co. Ltd., Nantong Acetic Acid Chemical Co. Ltd., Shandong Hongda Biological Technology Co. Ltd., Tianjin Zhongrui Pharmaceutical Co. Ltd., Vertellus Holdings LLC, Zhejiang Lanbo Biotechnology Co. Ltd.

The data-centric report focuses on market trends, status and outlook for segments. With comprehensive coverage of the market across different market segments, the report is a valuable asset for the existing players, new entrants and the future investors.

Why buy this report?
– Get a detailed picture of the China Nicotinamide Market
– Identify segments/areas to invest in over the forecast period in the China Nicotinamide Market
– Understand the competitive environment, the market’s leading players
– The market estimate for ease of analysis across scenarios in Excel format.
– Strategy consulting and research support for three months.
– Print authentication provided for the single-user license.